|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1999-3-10
|
|
pubmed:abstractText |
The objective of this trial was to assess the therapeutic activity and toxicity of ifosfamide (IFO) with mesna uroprotection as salvage therapy in patients (pts) with soft tissue sarcomas (STS) who had failed high-dose epirubicin treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0009-9074
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
149
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
331-3
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10052244-Adult,
pubmed-meshheading:10052244-Aged,
pubmed-meshheading:10052244-Antibiotics, Antineoplastic,
pubmed-meshheading:10052244-Antineoplastic Agents, Alkylating,
pubmed-meshheading:10052244-Drug Resistance, Neoplasm,
pubmed-meshheading:10052244-Epirubicin,
pubmed-meshheading:10052244-Female,
pubmed-meshheading:10052244-Humans,
pubmed-meshheading:10052244-Ifosfamide,
pubmed-meshheading:10052244-Male,
pubmed-meshheading:10052244-Middle Aged,
pubmed-meshheading:10052244-Sarcoma
|
|
pubmed:articleTitle |
Single-agent ifosfamide in the treatment of anthracycline-refractory adult sarcomas.
|
|
pubmed:affiliation |
Regina Elena Institute for Cancer Research, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Clinical Trial, Phase II
|
